Breaking News, Collaborations & Alliances

Intravacc and Primrose Bio Partner to Enhance Conjugate Vaccine Development

Will leverage their combined experience in the development of conjugate vaccines to offer a seamless solution.

Author Image

By: Charlie Sternberg

Associate Editor

Intravacc, a global contract development and manufacturing organization (CDMO) specializing in infectious disease and therapeutic vaccines, and Primrose Bio, a biotechnology company with technologies that improve the manufacturing of next-generation therapeutics, have partnered to enhance the development and supply of conjugate vaccines.   This partnership aims to harness the strengths of both companies. Intravacc contributes its technical expertise, facilities, and capabilities in antigen con...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters